HP and systemic lupus erythematosus: The observed pattern of plasma zonulin levels—characterized by lower concentrations in the control group compared to the SLE one, higher levels in SLE patients without clinical articular involvement, and moderately elevated levels in those with joint manifestations—suggests that a progressive decline in plasma zonulin concentration upon serial measurements may represent a potential predictive biomarker for the onset of clinical articular involvement in SLE.